198 related articles for article (PubMed ID: 37507599)
1. Use and efficacy of dry-mouth interventions in Sjögren's disease patients and possible association with perceived oral dryness and patients' discomfort.
Assy Z; van Santen JS; Brand HS; Bikker FJ
Clin Oral Investig; 2023 Sep; 27(9):5529-5537. PubMed ID: 37507599
[TBL] [Abstract][Full Text] [Related]
2. The association between oral dryness and use of dry-mouth interventions in Sjögren's syndrome patients.
Assy Z; Bikker FJ; Picauly O; Brand HS
Clin Oral Investig; 2022 Feb; 26(2):1465-1475. PubMed ID: 34374853
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the severity of oral dryness and the use of dry-mouth interventions by various subgroups of dry-mouth patients.
Assy Z; Brand HS; Bots CP; Bikker FJ
Clin Oral Investig; 2022 Mar; 26(3):3097-3108. PubMed ID: 35006295
[TBL] [Abstract][Full Text] [Related]
4. Oral health status, related behaviours and perceived stress in xerostomia, Sicca and Sjögren's syndromes patients - a cross-sectional study.
Stankeviciene I; Stangvaltaite-Mouhat L; Aleksejuniene J; Mieliauskaite D; Talijuniene I; Butrimiene I; Bendinskaite R; Puriene A
BMC Oral Health; 2024 Apr; 24(1):454. PubMed ID: 38622697
[TBL] [Abstract][Full Text] [Related]
5. The experience of dry mouth and screening for Sjogren's syndrome by the dentist: patient-reported experiences.
Rihab B; Lina EH; Noémie ST; Jean S; Marjolaine G
BMC Oral Health; 2023 Dec; 23(1):1010. PubMed ID: 38102574
[TBL] [Abstract][Full Text] [Related]
6. Differences in perceived intra-oral dryness in various dry-mouth patients as determined using the Regional Oral Dryness Inventory.
Assy Z; Bots CP; Arisoy HZ; Gülveren SS; Bikker FJ; Brand HS
Clin Oral Investig; 2021 Jun; 25(6):4031-4043. PubMed ID: 33496869
[TBL] [Abstract][Full Text] [Related]
7. Interventions for the management of dry mouth: topical therapies.
Furness S; Worthington HV; Bryan G; Birchenough S; McMillan R
Cochrane Database Syst Rev; 2011 Dec; (12):CD008934. PubMed ID: 22161442
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive overview of living with Sjögren's: results of a National Sjögren's Foundation survey.
McCoy SS; Woodham M; Bunya VY; Saldanha IJ; Akpek EK; Makara MA; Baer AN
Clin Rheumatol; 2022 Jul; 41(7):2071-2078. PubMed ID: 35257256
[TBL] [Abstract][Full Text] [Related]
9. The lived experience of Sjögren's Syndrome.
Ngo DYJ; Thomson WM; Nolan A; Ferguson S
BMC Oral Health; 2016 Feb; 16():7. PubMed ID: 26831141
[TBL] [Abstract][Full Text] [Related]
10. Oral manifestations in patients with Sjögren's syndrome.
Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
J Rheumatol; 1998 May; 25(5):906-10. PubMed ID: 9598889
[TBL] [Abstract][Full Text] [Related]
11. Dry Mouth and Clinical Oral Dryness Scoring Systems.
Das P; Challacombe SJ
Prim Dent J; 2016 Feb; 5(1):77-79. PubMed ID: 29029657
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the management of dry mouth: non-pharmacological interventions.
Furness S; Bryan G; McMillan R; Birchenough S; Worthington HV
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD009603. PubMed ID: 24006231
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical efficacy of Biotène Oral Balance in patients with secondary Sjögren's syndrome: a pilot study.
Aliko A; Alushi A; Tafaj A; Isufi R
Rheumatol Int; 2012 Sep; 32(9):2877-81. PubMed ID: 21898068
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
15. Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study.
Tashbayev B; Garen T; Palm Ø; Chen X; Herlofson BB; Young A; Hove LH; Rykke M; Singh PB; Aqrawi LA; Utheim ØA; Utheim TP; Jensen JL
Sci Rep; 2020 Feb; 10(1):2063. PubMed ID: 32034249
[TBL] [Abstract][Full Text] [Related]
16. Patient satisfaction and impact of salivary flow rate on effectiveness of xerostomia products.
Purdie MJ; Carpenter MD; Noll JL; Stephens CL; Taylor YJ; Hammitt KM; Napenas JJ; Brennan MT
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):236-241. PubMed ID: 36266177
[TBL] [Abstract][Full Text] [Related]
17. Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.
van der Reijden WA; Vissink A; Veerman EC; Amerongen AV
Ann Rheum Dis; 1999 Aug; 58(8):465-74. PubMed ID: 10419864
[No Abstract] [Full Text] [Related]
18. Long-term effectiveness of a novel intra-oral electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham-controlled feasibility study (LEONIDAS-1).
Fedele S; Al-Hamad A; Mercadante V; Porter S; Isenberg D; Poveda-Gallego A; Brown ST
J Oral Pathol Med; 2023 Aug; 52(7):619-627. PubMed ID: 37220073
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in perceived oral dryness as determined with a newly developed questionnaire, the Regional Oral Dryness Inventory.
Assy Z; Jager DHJ; Mashhour E; Bikker FJ; Brand HS
Clin Oral Investig; 2020 Nov; 24(11):4051-4060. PubMed ID: 32382921
[TBL] [Abstract][Full Text] [Related]
20. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
Alves MB; Motta AC; Messina WC; Migliari DA
Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
